Loading clinical trials...
Loading clinical trials...
A Phase 2, Single-Arm, Open-Label, Single Center Study to Assess Efficacy and Safety of Tirbanibulin Ointment 1% in Adult Subjects With Superficial Basal Cell Carcinoma (sBCC) on the Neck, Trunk, or Extremities (Excluding Axilla, Anogenital, and Face/Scalp)
Conditions
Interventions
Tirbanibulin Ointment 1%
Locations
1
United States
Austin Institute for Clinical Research, Inc.
Pflugerville, Texas, United States
Start Date
April 17, 2023
Primary Completion Date
March 7, 2024
Completion Date
March 7, 2024
Last Updated
July 19, 2024
Lead Sponsor
Austin Institute for Clinical Research
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions